REFERENCES
- Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012; 307: 1934–40.
- Gyarmathy VA, Giraudon I, Hedrich D, Montanari L, Guarita B, Wiessing L. Drug use and pregnancy - challenges for public health. Euro Surveill 2009; 14:33–6.
- World Health Organization. Guidelines for the psychosicially assisted pharmacological treatment of opioid dependence. Geneva, Switzerland: WHO Press, 2009.
- Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome: a national prospective study. Eur Addict Res 2009; 15:128–34.
- Slinning K. Foster placed children prenatally exposed to poly-substances: attention-related problems at ages 2 and 4 1/2. Eur Child Adolesc Psychiatry 2004; 13:19–27.
- Moe V, Slinning K. Children prenatally exposed to substances: gender-related differences in outcome from infancy to 3 years of age. Infant Mental Health Journal 2001; 22:334–50.
- Moe V. Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years. J Dev Behav Pediatr 2002; 23:330–9.
- Konijnenberg C, Melinder A. Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy. Addiction 2013; 108:154–60.
- Hans SL, Jeremy RJ. Postneonatal mental and motor development of infants exposed in utero to opioid drugs. Infant Mental Health Journal 2001; 22:300–15.
- Wang Y, Han TZ. Prenatal exposure to heroin in mice elicits memory deficits that can be attributed to neuronal apoptosis. Neuroscience 2009; 160:330–8.
- Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002; 42:829–36.
- Harlan RE, Song DD. Prenatal morphine treatment and the development of the striatum. Regulatory Peptides 1994; 54:117–8.
- Walhovd KB, Watts R, Amlien I, Woodward LJ. Neural tract development of infants born to methadone-maintained mothers. Pediatr Neurol 2012; 47:1–6.
- Norwegian Directorate of Health. National guidelines for pregnant women in opioid maintainance treatment. Norway: Norwegian Directorate of Health; 2011.
- Norwegian Directorate of Health. National guidelines for women in medicated assistance treatment and the follow-up of the families until school-age. Oslo, Norway: Norwegian Directorate of Health, 2011.
- Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 2003; 24:363–7.
- McCarthy JJ. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern-Fetal Neonatal Med 2012; 25:109–12.
- Moe V, Slinning K. Prenatal drug exposure and the conceptualization of long-term effects. Scand J Psychol 2002; 43:41–7.
- McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199–213.
- Finnegan LP, Connaughton JF Jr., Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2:141–58.
- England LJ, Kendrick JS, Wilson HG, Merritt RK, Gargiullo PM, Zahniser SC. Effects of smoking reduction during pregnancy on the birth weight of term infants. Am J Epidemiol 2001; 154:694–701.
- Secker-Walker RH, Vacek PM, Flynn BS, Mead PB. Estimated gains in birth weight associated with reductions in smoking during pregnancy. J Reprod Med 1998; 43:967–74.
- Hans SL, Bernstein VJ, Henson LG. The role of psychopathology in the parenting of drug-dependent women. Dev Psychopathol 1999; 11:957–77.
- Luthar SS, Cushing G, Merikangas KR, Rounsaville BJ. Multiple jeopardy: Risk and protective factors among addicted mothers’ offspring. Dev Psychopathol 1998; 10:117–36.